Ancora Advisors LLC Raises Stake in ZimVie Inc. (NASDAQ:ZIMV)

Ancora Advisors LLC grew its holdings in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 460.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 112,160 shares of the company's stock after purchasing an additional 92,160 shares during the quarter. Ancora Advisors LLC owned 0.41% of ZimVie worth $1,565,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in ZIMV. Barclays PLC boosted its position in ZimVie by 338.4% in the 3rd quarter. Barclays PLC now owns 43,437 shares of the company's stock valued at $690,000 after buying an additional 33,529 shares during the period. Principal Financial Group Inc. purchased a new position in ZimVie in the third quarter valued at $275,000. JPMorgan Chase & Co. grew its stake in ZimVie by 66.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company's stock worth $2,911,000 after purchasing an additional 73,395 shares in the last quarter. Monarch Capital Management Inc. increased its holdings in ZimVie by 6.2% during the 4th quarter. Monarch Capital Management Inc. now owns 65,560 shares of the company's stock worth $915,000 after purchasing an additional 3,847 shares during the period. Finally, SG Americas Securities LLC raised its position in ZimVie by 15.7% in the 4th quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock valued at $155,000 after purchasing an additional 1,508 shares in the last quarter. Institutional investors and hedge funds own 95.63% of the company's stock.

ZimVie Stock Down 4.7 %

NASDAQ ZIMV traded down $0.43 during trading on Friday, reaching $8.76. 249,399 shares of the company's stock were exchanged, compared to its average volume of 215,098. The stock has a market cap of $243.94 million, a P/E ratio of -0.67 and a beta of 2.16. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. ZimVie Inc. has a 1 year low of $8.56 and a 1 year high of $22.40. The company has a 50 day moving average price of $10.32 and a two-hundred day moving average price of $12.64.

ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.27 earnings per share for the quarter. The firm had revenue of $112.00 million during the quarter, compared to analysts' expectations of $113.10 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. On average, equities research analysts anticipate that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ZIMV. B. Riley started coverage on ZimVie in a research report on Thursday, April 10th. They set a "buy" rating and a $16.00 price objective for the company. Needham & Company LLC reiterated a "hold" rating on shares of ZimVie in a report on Wednesday, April 9th.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.